CHICAGO, IL— Sacubitril/valsartan shows promise as an antiarrhythmic agent among older patients with hypertension who are ...
These findings suggest cautious statin discontinuation in primary prevention only after shared decision-making,” Nicolas ...
Some continue to use it routinely, given data favoring clopidogrel monotherapy, but others struggle to see a future for this ...
The cardiac myosin inhibitor has the potential to transform the lives of children with obstructive HCM, Joseph Rossano says.
Conferring skills and sustained ability to understand and use CPR in emergencies remains a challenge, says Brahmajee ...
Investigators say finding the optimal heparin dose is important, although identifying that sweet spot remains elusive.
The drug failed to reduce CV events in the RCT, but it’s clear many still hold out hope for the inflammatory hypothesis.
The supervised intervention seemed to be durable, suggesting patients learned things that may help them in the long term.
Patients had fewer MACE over 4 years compared with a standard systolic target, but some had worsened renal function.
MAR001 successfully lowered triglyceride levels in the phase IIa trial, but whether this reduces CV risk isn’t yet known.
One trial does not disprove the concept that lowering Lp(a) can reduce CV risk, Steven Nissen stresses, with “more work to do ...
The IRIS-MAIN registry results did show some differences in nonfatal outcomes like stroke, MI, and revascularization.